Actavis obtains final approval from FDA for generic Subutex

Download PDF Copy

Feb 21 2015

NewsGuard 100/100 Score

Actavis plc (NYSE: ACT) today announced that it has received final approval from the U.S. Food and Drug Administration on its Abbreviated New Drug Application for a generic version of Reckitt Benckiser's Subutex^® (Buprenorphine 2 mg and 8 mg sublingual tablets). Actavis intends to begin shipping its product shortly.

Subutex^® is indicated for the treatment of opioid dependence. For the 12 months ending December 31, 2014, Subutex^® had total U.S. sales of approximately $108 million, according to IMS Health data.

Source:

Actavis plc

Posted in: Pharmaceutical News

Tags: Food, Gastroenterology, Healthcare, Nervous System, New Drug Application, Opioid Dependence, Respiratory, Urology

Comments (0)

Download PDF Copy

Suggested Reading

Living in food deserts during early childhood raises long-term obesity risk

Living in food deserts during early childhood raises long-term obesity risk

Six common flying with food allergies myths

Six common flying with food allergies myths

Limiting fast-food outlets can reduce childhood overweight and obesity

Limiting fast-food outlets can reduce childhood overweight and obesity

Social media normalizes unhealthy food choices, shaping youth habits and brand loyalty

High levels of microplastics found in prostate tumors, possibly linked to take-out food

High levels of microplastics found in prostate tumors, possibly linked to take-out food

Not all ultra-processed foods are made alike: Researchers warn against villainizing entire food group

Not all ultra-processed foods are made alike: Researchers warn against villainizing entire food group

Frequent ultra-processed food consumption raises mortality risks, especially in women

Frequent ultra-processed food consumption raises mortality risks, especially in women

Key triggers for food allergies in children after organ transplants

Key triggers for food allergies in children after organ transplants

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

Post

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...

Ultra-processed foods dominate children's diets from toddlerhood to middle childhood